Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach

The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. Identification of effective therapeutics is a crucial tool to treat those infected with SARS-CoV-2 and limit the spread of this novel disease globally. W...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donovan, Sinead M., Imami, Ali, Eby, Hunter, Henkel, Nicholas D., Creeden, Justin Fortune, Asah, Sophie, Zhang, Xiaolu, Wu, Xiaojun, Alnafisah, Rawan, Taylor, R. Travis, Reigle, James, Thorman, Alexander, Shamsaei, Behrouz, Meller, Jarek, McCullumsmith, Robert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904823/
https://www.ncbi.nlm.nih.gov/pubmed/33627767
http://dx.doi.org/10.1038/s41598-021-84044-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904823/
https://www.ncbi.nlm.nih.gov/pubmed/33627767
http://dx.doi.org/10.1038/s41598-021-84044-9

Ejemplares similares